Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Slominski, Andrzej T ^a,b   Kim, Tae Kang ^a   Li, Wei ^c   Postlethwaite, Arnold ^d,e   Tieu, Elaine W ^f   Tang, Edith K Y ^f   Tuckey, Robert C ^f  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c Departments of Pharmaceutical Sciences   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

7 DEHYDROCHOLESTEROL; 7-DEHYDROCHOLESTEROL; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); COLECALCIFEROL; SECOSTEROID;

ADRENAL GLAND; ANIMAL; BLOOD; CHEMISTRY; EPIDERMIS; HUMAN; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; PIG;

ADRENAL GLANDS; ANIMALS; CHOLECALCIFEROL; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; DEHYDROCHOLESTEROLS; EPIDERMIS; HUMANS; SECOSTEROIDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SWINE;

EID: 84943565325     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14875     Document Type: Article

References (61)

1. MacLaughlin, J. A., Anderson, R. R. & Holick, M. F. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 216, 1001-1003 (1982).
2. Holick, M. F. Vitamin D: A millenium perspective. J Cell Biochem 88, 296-307, doi: 10.1002/jcb.10338 (2003).
3. Bikle, D. D. Vitamin D: an ancient hormone. Experimental Dermatology 20, 7-13 (2011).
4. Holick, M. F. Vitamin D deficiency. N Engl J Med 357, 266-281, doi: 10.1056/NEJMra070553 (2007).
5. Jones, G., Prosser, D. E. & Kaufmann, M. Cytochrome P450-mediated metabolism of vitamin D. J Lipid Res 55, 13-31, doi: 10.1194/jlr.R031534 (2014).
6. Sawada, N. et al. Enzymatic properties of human 25-hydroxyvitamin D3 1alpha-hydroxylase coexpression with adrenodoxin and NADPH-Adrenodoxin reductase in Escherichia coli. Eur J Biochem 265, 950-956 (1999).
7. Sakaki, T., Sawada, N., Takeyama, K., Kato, S. & Inouye, K. Enzymatic properties of mouse 25-hydroxyvitamin D3 1 alphahydroxylase expressed in Escherichia coli. Eur J Biochem 259, 731-738 (1999).
8. Bikle, D. D. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol 347, 80-89, doi: 10.1016/j.mce.2011.05.017 (2011).
9. Lehmann, B., Genehr, T., Knuschke, P., Pietzsch, J. & Meurer, M. UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol 117, 1179-1185, doi: 10.1046/j.0022-202x.2001.01538.x (2001).
10. Hewison, M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 7, 337-345, doi: 10.1038/nrendo.2010.226 (2011).
11. Hewison, M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 76, 315-325, doi: 10.1111/j.1365-2265.2011.04261.x (2012).
12. Plum, L. A. & DeLuca, H. F. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 9, 941-955, doi: 10.1038/nrd3318 (2010).
13. Bikle, D. D. The vitamin D receptor: a tumor suppressor in skin. Discov Med 11, 7-17 (2011).
14. Mason, R. S. & Reichrath, J. Sunlight vitamin D and skin cancer. Anticancer Agents Med Chem 13, 83-97 (2013).
15. Schuster, I. Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 1814, 186-199, doi: 10.1016/j.bbapap.2010.06.022 (2011).
16. Tieu, E. W., Tang, E. K. & Tuckey, R. C. Kinetic analysis of human CYP24A1 metabolism of vitamin D via the C24-oxidation pathway. The FEBS journal 281, 3280-3296, doi: 10.1111/febs.12862 (2014).
17. Sakaki, T. et al. Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. Eur J Biochem 267, 6158-6165 (2000).
18. Miller, W. L. & Auchus, R. J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocrine Reviews 32, 81-151, doi: 10.1210/er.2010-0013 (2011).
19. Tuckey, R. C. Progesterone synthesis by the human placenta. Placenta 26, 273-281, doi: 10.1016/j.placenta.2004.06.012 (2005).
20. Guryev, O., Carvalho, R. A., Usanov, S., Gilep, A. & Estabrook, R. W. A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc Natl Acad Sci USA 100, 14754-14759, doi: 10.1073/pnas.2336107100 (2003).
21. Slominski, A. et al. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem 271, 4178-4188 (2004).
22. Slominski, A. et al. Enzymatic metabolism of ergosterol by cytochrome p450scc to biologically active 17alpha,24-dihydroxyergosterol. Chem Biol 12, 931-939 (2005).
23. Slominski, A. et al. The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J 272, 4080-4090 (2005).
24. Tuckey, R. C. et al. Human cytochrome P450scc (CYP11A1) catalyzes epoxide formation with ergosterol. Drug Metab Dispos 40, 436-444, doi: 10.1124/dmd.111.042515 (2012).
25. Tuckey, R. C. et al. Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J 275, 2585-2596 (2008).
26. Slominski, A. T. et al. Novel activities of CYP11A1 and their potential physiological significance. J Steroid Biochem Mol Biol 151, 25-37, doi: 10.1016/j.jsbmb.2014.11.010 (2015).
27. Slominski, A. T. et al. The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. J Steroid Biochem Mol Biol 144PA, 28-39, doi: 10.1016/j.jsbmb.2013.10.012 (2014).
28. Tieu, E. W. et al. Metabolism of cholesterol, vitamin D3 and 20-hydroxyvitamin D3 incorporated into phospholipid vesicles by human CYP27A1. J Steroid Biochem Mol Biol 129, 163-171, doi: 10.1016/j.jsbmb.2011.11.012 (2012).
29. Tieu, E. W. et al. Rat CYP24A1 acts on 20-hydroxyvitamin D(3) producing hydroxylated products with increased biological activity. Biochem Pharmacol 84, 1696-1704, doi: 10.1016/j.bcp.2012.09.032 (2012).
30. Tieu, E. W. et al. Metabolism of 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3 by rat and human CYP24A1. J Steroid Biochem Mol Biol 149, 153-165, doi: 10.1016/j.jsbmb.2015.02.010 (2015).
31. Tang, E. K. et al. Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity. Drug Metab Dispos 38, 1553-1559, doi: 10.1124/dmd.110.034389 (2010).
32. Tang, E. K. et al. Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1. Drug Metab Dispos 41, 1112-1124, doi: 10.1124/dmd.113.050955 (2013).
33. Zbytek, B. et al. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol 128, 2271-2280 (2008).
34. Janjetovic, Z. et al. 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One 4, e5988 (2009).
35. Janjetovic, Z., Tuckey, R. C., Nguyen, M. N., Thorpe, E. M., Jr. & Slominski, A. T. 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. J Cell Physiol 223, 36-48 (2010).
36. Li, W. et al. Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity. Steroids 75, 926-935, doi: 10.1016/j.steroids.2010.05.021 (2010).
37. Zmijewski, M. A. et al. Synthesis and photochemical transformation of 3 beta,21-dihydroxypregna-5,7-dien-20-one to novel secosteroids that show anti-melanoma activity. Steroids 76, 193-203, doi: 10.1016/j.steroids.2010.10.009 (2011).
38. Slominski, A. et al. Novel vitamin D photoproducts and their precursors in the skin. Dermato-Endocrinology 5, 1-13, doi: http://dx.doi.org/10.4161/derm.23938 (2013).
39. Slominski, A. et al. 20S-Hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo. J Clin Endocrinol Metab 98, E298-303, doi: 10.1210/jc.2012-3074 (2013).
40. Slominski, A. T. et al. 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. Am J Physiol Cell Physiol 300, C526-541, doi: 10.1152/ajpcell.00203.2010 (2011).
41. Slominski, A. T. et al. Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes. Anticancer Res 32, 3733-3742 (2012).
42. Wang, J. et al. 20-hydroxyvitamin D(3) inhibits proliferation of cancer cells with high efficacy while being non-toxic. Anticancer Res 32, 739-746 (2012).
43. Janjetovic, Z. et al. High basal NF-kappaB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives. Br J Cancer 105, 1874-1884, doi: 10.1038/bjc.2011.458 (2011).
44. Slominski, A. T. et al. Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. PLoS One 5, e9907 (2010).
45. Kim, T. K. et al. Correlation between secosteroid-induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength. Mol Cell Endocrinol 361, 143-152, doi: 10.1016/j.mce.2012.04.001 (2012).
46. Slominski, A. T. et al. RORalpha and ROR gamma are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy-And 20,23-dihydroxyvitamin D. FASEB J 28, 2775-2789, doi: 10.1096/fj.13-242040 (2014).
47. Chen, J. et al. Novel vitamin d analogs as potential therapeutics: metabolism, toxicity profiling, and antiproliferative activity. Anticancer Res 34, 2153-2163 (2014).
48. Slominski, A. T. et al. Sequential metabolism of 7-dehydrocholesterol to steroidal 5,7-dienes in adrenal glands and its biological implication in the skin. PLoS One 4, e4309, doi: 10.1371/journal.pone.0004309 (2009).
49. Slominski, A. T. et al. Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes. Int J Biochem Cell Biol 44, 2003-2018, doi: 10.1016/j.biocel.2012.07.027 (2012).
50. Slominski, A. T. et al. In vivo evidence for a novel pathway of vitamin D(3) metabolism initiated by P450scc and modified by CYP27B1. FASEB J 26, 3901-3915, doi: 10.1096/fj.12-208975 (2012).
51. Slominski, A. T. et al. In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. Mol Cell Endocrinol 383, 181-192, doi: 10.1016/j.mce.2013.12.012 (2014).
52. Slominski, A. et al. Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol 137, 107-123, doi: 10.1016/j.jsbmb.2013.02.006 (2013).
53. Zmijewski, M. A. et al. Synthesis and photo-conversion of androsta-And pregna-5,7-dienes to vitamin D3-like derivatives. Photochem Photobiol Sci 7, 1570-1576, doi: 10.1039/b809005j (2008).
54. Zmijewski, M. A. et al. Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3 beta, 17 alpha, 20-triol and their bioactivity in melanoma cells. Steroids 74, 218-228, doi: 10.1016/j.steroids.2008.10.017 (2009).
55. Chen, J., Slominski, A. T., Miller, D. D. & Li, W. Effects of sidechain length and composition on the kinetic conversion and product distribution of vitamin D analogs determined by real-time NMR. Dermatoendocrinol 5, 142-149, doi: 10.4161/derm.24339 (2013).
56. Slominski, A. T. et al. Novel non-calcemic secosteroids that are produced by human epidermal keratinocytes protect against solar radiation. J Steroid Biochem Mol Biol 148, 52-63, doi: 10.1016/j.jsbmb.2015.01.014 (2015).
57. Tuckey, R. C. et al. Production of 22-hydroxy metabolites of vitamin D3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells. Drug Metab Dispos 39, 1577-1588, doi: 10.1124/dmd.111.040071 (2011).
58. Cheng, C. Y., Slominski, A. T. & Tuckey, R. C. Metabolism of 20-hydroxyvitamin D3 by mouse liver microsomes. J Steroid Biochem Mol Biol 144 Pt B, 286-293, doi: 10.1016/j.jsbmb.2014.08.009 (2014).
59. Tang, E. K., Voo, K. J., Nguyen, M. N. & Tuckey, R. C. Metabolism of substrates incorporated into phospholipid vesicles by mouse 25-hydroxyvitamin D3 1alpha-hydroxylase (CYP27B1). J Steroid Biochem Mol Biol 119, 171-179, doi: 10.1016/j.jsbmb.2010.02.022 (2010).
60. Tuckey, R. C. et al. Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 112, 213-219, doi: 10.1016/j.jsbmb.2008.10.005 (2008).
61. Kim, T. K., Lin, Z., Tidwell, W. J., Li, W. & Slominski, A. T. Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro. Mol Cell Endocrinol 404, 1-8, doi: 10.1016/j.mce.2014.07.024 (2015).